(Q44532772)

English

Pioglitazone reduces neointimal tissue proliferation after coronary stent implantation in patients with type 2 diabetes mellitus: an intravascular ultrasound scanning study

scientific article published in August 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

3 December 2017

Pioglitazone reduces neointimal tissue proliferation after coronary stent implantation in patients with type 2 diabetes mellitus: an intravascular ultrasound scanning study (English)

1 reference

Europe PubMed Central

3 December 2017

type 2 diabetes

1 reference

based on heuristic

inferred from title

intravascular ultrasound

1 reference

based on heuristic

inferred from title

author name string

Tsutomu Takagi

1

1 reference

Europe PubMed Central

3 December 2017

Atsushi Yamamuro

2

1 reference

Europe PubMed Central

3 December 2017

Koichi Tamita

3

1 reference

Europe PubMed Central

3 December 2017

Kenji Yamabe

4

1 reference

Europe PubMed Central

3 December 2017

Minako Katayama

5

1 reference

Europe PubMed Central

3 December 2017

Shin Mizoguchi

6

1 reference

Europe PubMed Central

3 December 2017

Motoaki Ibuki

7

1 reference

Europe PubMed Central

3 December 2017

Tomoko Tani

8

1 reference

Europe PubMed Central

3 December 2017

Kazuaki Tanabe

9

1 reference

Europe PubMed Central

3 December 2017

Kunihiko Nagai

10

1 reference

Europe PubMed Central

3 December 2017

Kenichi Shiratori

11

1 reference

Europe PubMed Central

3 December 2017

Shigefumi Morioka

12

1 reference

Europe PubMed Central

3 December 2017

Junichi Yoshikawa

13

1 reference

Europe PubMed Central

3 December 2017

language of work or name

0 references

publication date

1 August 2003

1 reference

Europe PubMed Central

3 December 2017

American Heart Journal

1 reference

Europe PubMed Central

3 December 2017

146

1 reference

Europe PubMed Central

3 December 2017

2

1 reference

Europe PubMed Central

3 December 2017

E5

1 reference

Europe PubMed Central

3 December 2017

A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900146-7

7 January 2021

Midterm angiographic outcome of single-vessel intracoronary stent placement in diabetic versus nondiabetic patients: a matched comparative study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900146-7

7 January 2021

Diabetes mellitus and the clinical and angiographic outcome after coronary stent placement

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900146-7

7 January 2021

Primary stenting in acute myocardial infarction: influence of diabetes mellitus in angiographic results and clinical outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900146-7

7 January 2021

Neointimal tissue response at sites of coronary stenting in humans: macroscopic, histological, and immunohistochemical analyses.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900146-7

7 January 2021

Pathology of Acute and Chronic Coronary Stenting in Humans

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900146-7

7 January 2021

Increased restenosis in diabetes mellitus after coronary interventions is due to exaggerated intimal hyperplasia. A serial intravascular ultrasound study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900146-7

7 January 2021

Troglitazone reduces neointimal tissue proliferation after coronary stent implantation in patients with non-insulin dependent diabetes mellitus: a serial intravascular ultrasound study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900146-7

7 January 2021

Impact of troglitazone on coronary stent implantation using small stents in patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900146-7

7 January 2021

Hepatic dysfunction associated with troglitazone

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900146-7

7 January 2021

Vasculo-protective effects of insulin sensitizing agent pioglitazone in neointimal thickening and hypertensive vascular hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900146-7

7 January 2021

Intravascular ultrasound analysis of reduction in progression of coronary narrowing by treatment with pravastatin

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900146-7

7 January 2021

Pioglitazone hydrochloride monotherapy improves glycemic control in the treatment of patients with type 2 diabetes: a 6-month randomized placebo-controlled dose-response study. The Pioglitazone 001 Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900146-7

7 January 2021

Improved glycemic control and enhanced insulin sensitivity in type 2 diabetic subjects treated with pioglitazone

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900146-7

7 January 2021

Pioglitazone hydrochloride in combination with sulfonylurea therapy improves glycemic control in patients with type 2 diabetes mellitus: a randomized, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900146-7

7 January 2021

PPAR gamma-ligands inhibit migration mediated by multiple chemoattractants in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900146-7

7 January 2021

Pioglitazone reduces smooth muscle cell density of rat carotid arterial intima induced by balloon catheterization

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900146-7

7 January 2021

Characterization of an inhibitory effect of pioglitazone on balloon-injured vascular smooth muscle cell growth

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900146-7

7 January 2021

Pioglitazone enhances cytokine-induced apoptosis in vascular smooth muscle cells and reduces intimal hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900146-7

7 January 2021

Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900146-7

7 January 2021

Troglitazone suppresses intimal formation following balloon injury in insulin-resistant Zucker fatty rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900146-7

7 January 2021

Hyperinsulinemia during oral glucose tolerance test is associated with increased neointimal tissue proliferation after coronary stent implantation in nondiabetic patients: a serial intravascular ultrasound study.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900146-7

7 January 2021

The prevention or delay of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900146-7

7 January 2021

Effect of statin therapy on restenosis after coronary stent implantation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900146-7

7 January 2021

Statin therapy, inflammation and recurrent coronary events in patients following coronary stent implantation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900146-7

7 January 2021

Myocardial infarction and prevalence of diabetes mellitus. Is increased casual blood glucose at admission a reliable criterion for the diagnosis of diabetes?

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900146-7

7 January 2021

Variations in lipoproteins, hormones and blood glucose during the early acute phase of myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900146-7

7 January 2021

Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900146-7

7 January 2021

Intravascular ultrasound predictors of angiographic restenosis in lesions treated with Palmaz-Schatz stents

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900146-7

7 January 2021

Identifiers

10.1016/S0002-8703(03)00146-7

1 reference

Europe PubMed Central

3 December 2017

1 reference

Europe PubMed Central

3 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44532772&oldid=2027026695"